ImmunoCellular To Present Encouraging Phase 1 Study Results For Brain Tumour Treatment
ImmunoCellular Therapeutics will present positive results from a phase 1 clinical study on its ICT-107 therapy, a treatment for a type of brain tumor.
proactive
Access Pharmaceuticals Inks Deal To Expand MuGard Distribution
Access Pharmaceuticals announced Tuesday it has signed an agreement with eMax Health Systems to expand the distribution of the company’s MuGard treatment.
Valeant Pharmaceuticals to acquire Lithuania’s Sanitas for $442m
Valeant Pharmaceuticals said Tuesday that it agreed to buy Lithuania-based generic drug company Sanitas for €314 million in cash.
NeoStem’s Suzhou Erye Receives 2 Pharma Industry Awards, Positioned For Future Growth
NeoStem announced Tuesday that Chinese generic pharma company Suzhou Erye, in which it owns a 51% majority stake, has won two awards at the 2011 Chempharm Brand Summit.